Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | TLR4 | O00206 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL443973 | 0.98 | MAPT (0.44) | MAPTALDH1A1KDM4EMEN1GAA | |
| Hydrochloric Acid SCHEMBL6282864 | 0.89 | MAPT (0.42) | MAPTALDH1A1KDM4EMEN1GAA | |
| Bromide SCHEMBL6281750 | 0.89 | MAPT (0.40) | MAPTALDH1A1KDM4EMEN1GAA | |
| SCHEMBL16925388 | 0.85 | MAPT (0.45) | MAPTALDH1A1KDM4EMEN1GAA | |
| SCHEMBL8242838 | 0.84 | MAPT (0.37) | MAPTALDH1A1KDM4EMEN1GAA | |
| SCHEMBL6346612 | 0.83 | MAPT (0.45) | MAPTALDH1A1KDM4EMEN1GAA | |
| SCHEMBL19402623 | 0.83 | TLR4 (0.46) | MAPTALDH1A1KDM4EMEN1GAA | |
| SCHEMBL7722190 | 0.82 | MAPT (0.38) | MAPTALDH1A1KDM4EMEN1GAA | |
| SCHEMBL567797 | 0.81 | CHRNB2 (0.39) | KDM4EKMT2AHSD17B10 | |
| SCHEMBL28345166 | 0.81 | CHRNB2 (0.39) | KDM4EKMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0088024-B1 | PYRIDO(3,4-C)PSORALENES, PREPARATION, USE IN COSMETOLOGY AND IN MEDICINE AND COMPOSITIONS CONTAINING THEM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1986-09-17 | — | — | EP | claimed |
| US-20260060985-A1 | Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof | GALECTIN SCIENCES, LLC (US) | 2026-03-05 | — | — | US | disclosed |
| US-12377102-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | GALECTIN SCIENCES, LLC (US) | 2025-08-05 | — | — | US | disclosed |
| CN-109715162-B | Protein kinase modulators | 南京盖特医药技术有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2025011546-A1 | HUMAN CASEINOLYTIC PROTEASE P AGONISTS AND USES THEREOF | ACELON THERAPEUTICS (CN) | 2025-01-16 | — | — | WO | disclosed |
| CN-111032039-B | Compounds for the prevention and treatment of medical disorders and uses thereof | 卡莱克汀科学有限责任公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20230212122-A1 | MITOCHONDRIAL TARGETING COMPOUNDS FOR THE TREATMENT OF ASSOCIATED DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-07-06 | — | — | US | disclosed |
| US-20230116370-A1 | Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof | GALECTIN SCIENCES, LLC | 2023-04-13 | — | — | US | disclosed |
| EP-4157263-A1 | MITOCHONDRIAL TARGETING COMPOUNDS FOR THE TREATMENT OF ASSOCIATED DISEASES | The Regents Of The University Of Michigan (US) | 2023-04-05 | — | — | EP | disclosed |
| US-11583530-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | GALECTIN SCIENCES, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-4276296-A | Substituted benzopyrano[3,4-c]pyridines, compositions and use thereof | WARNER-LAMBERT COMPANY (US) | 1981-06-30 | — | — | US | disclosed |
| US-4018766-A | BRONCHODILATORS | WARNER-LAMBERT COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-4013671-A | Substituted benzopyrano[3,4-c]pyridines and process for their preparation | WARNER-LAMBERT COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
| US-4013671-A | Substituted benzopyrano[3,4-c]pyridines and process for their preparation | WARNER-LAMBERT COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
| US-3984546-A | Substituted benzopyrano [3,4-c]pyridines for the treatment of bronchial asthma | WARNER-LAMBERT COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
| US-3984546-A | Substituted benzopyrano [3,4-c]pyridines for the treatment of bronchial asthma | WARNER-LAMBERT COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
| US-3961057-A | Benzopyrano(3,4-C)pyridine bronchodilators | WARNER-LAMBERT COMPANY (US) | 1976-06-01 | — | — | US | disclosed |
| US-3961057-A | Benzopyrano(3,4-C)pyridine bronchodilators | WARNER-LAMBERT COMPANY (US) | 1976-06-01 | — | — | US | disclosed |
| US-3946008-A | Substituted benzopyrano[3,4-c]pyridines | WARNER-LAMBERT COMPANY (US) | 1976-03-23 | — | — | US | disclosed |
| US-3946008-A | Substituted benzopyrano[3,4-c]pyridines | WARNER-LAMBERT COMPANY (US) | 1976-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060985-A1 | Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof | LGALS3, LGALS1, LGALS2 | MAPT 2059/4885ALDH1A1 1833/4885KDM4E 4183/4885 |
| US-20230116370-A1 | Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof | LGALS1, LGALS2, LGALS3 | MAPT 1108/4885ALDH1A1 1242/4885KDM4E 4622/4885 |
| US-11583530-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | LGALS1, LGALS2, LGALS3 | MAPT 1108/4885ALDH1A1 1242/4885KDM4E 4622/4885 |
| US-20230212122-A1 | MITOCHONDRIAL TARGETING COMPOUNDS FOR THE TREATMENT OF ASSOCIATED DISEASES | TFAM, CS, FH | MAPT 1016/4885ALDH1A1 2339/4885KDM4E 1994/4885 |
| US-12377102-B2 | Compounds for the prevention and treatment of medical disorders and uses thereof | LGALS1, LGALS2, LGALS3 | MAPT 1108/4885ALDH1A1 1242/4885KDM4E 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.